Mitotic activity and nuclear DNA damage of large cells in Hodgkin's disease: Comparison with the expression of p53 and bcl-2 proteins and the presence of Epstein-Barr virus

Leukemia and Lymphoma

Volumn 25, Issue 1-2, 1997, Pages 153-161

  Leoncini, Lorenzo ^a   Spina, Donatella ^a   Close, Pauline ^b   Minacci, Chiara ^a   Megha, Tiziana ^a   De Luca, Fabio ^c   Tosi, Piero ^a   Pileri, Stefano ^c   Kraft, Rainer ^d   Laissue, Jean A ^d   Cottier, Hans ^e  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF BERN   (Switzerland)

^e NONE

Author keywords

Apoptosis; bcl 2 p53; EBV; Hodgkin's disease; Mitosis

Indexed keywords

CD30 ANTIGEN; CELL NUCLEUS DNA; ONCOPROTEIN; PROTEIN BCL 2; PROTEIN P53;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL COUNT; DNA DAMAGE; DNA STRAND BREAKAGE; EPSTEIN BARR VIRUS; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MITOSIS RATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REED STERNBERG CELL; VIRUS INFECTION;

EID: 8244252296     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199709042505     Document Type: Article

References (33)

1. Steel, G. G. (1977). Growth kinetics of tumours. Cell population kinetics in relation to the growth and treatment of cancer. (Oxford: Clarendon Press).
2. Korsmeyer, S. J. (1992). Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood, 80, 879-886.
3. Reed, J. C. (1994). Bcl-2 and the regulation of programmed cell death. J. Cell. Biol., 124, 1-6.
4. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B. and Craig, R. W. (1991). Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51, 6304-6311.
5. Lane, D. P. (1992). p53, guardian of the genome. Nature, 358, 15-16.
6. Prokocimer, M. and Rotter, V. (1994) Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hematologic cell lineages. Blood, 84, 2391-2411.
7. Rodrigues, N R., Rowan, A., Smith, M. E. F., Kerr, I. B., Bodmer, W. F., Gannon, J. V. and Lane, D. P. (1990). p53 mutations in colorectal cancer. Proc. Natl. Acad. Sci. USA, 87, 7555-7559.
8. Gupta, R. K., Norton, A. J., Thompson, I. W., Lister, T A. and Bodmer, J. G. (1992). p53 expression in Reed-Sternberg cells of Hodgkin's disease. Br J. Cancer, 66, 649-652.
9. Merino, R., Ding, L., Veis, D. J., Korsmeyer, S. J. and Nuñez, G. (1994). Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes. EMBO J., 13, 683-691.
10. Doussis, I. A., Pezzella, F., Lane, D. P., Gatter, K C and Mason, D. Y. (1993). An immunocytochemical study of p53 and bcl-2 protein expression in Hodgkin's disease Am. J. Clin. Pathol., 99, 663-667.
11. Leoncini, L., Del Vecchio, M. T., Spina, D., Megha, T., Barbini, P., Sabattini, E., Pileri, S., Tosi, P., Kraft, R., Laissue, J. A. and Cottier, H. (1995). Presence of the bcl-2 protein and apoptosis in non-Hodgkin lymphomas with diffuse growth pattern. Int. J. Cancer, 61, 826-831.
12. Xerri, L., Bouabdallah, R., Camerlo, J. and Hassoun, J. (1994). Expression of the p53 gene in Hodgkin's disease: dissociation between immunohistochemistry and clinicopathological data. Hum. Pathol., 25, 449-454.
13. Chilosi, M., Doglioni, C., Menestrina, F., Montagna, L., Rigo, A., Lestani, M., Barbareschi, M., Scarpa, A., Mariuzzi, G. M. and Pizzolo, G. (1994) Abnormal expression of the p53-binding protein MDM2 in Hodgkin's disease. Blood, 84, 4295-4300
14. Bhagat, S. K. M., Medeiros, L. J., Weiss, L. M., Wang, J., Raffeld, M. and Stetler-Stevenson, M (1993). bcl-2 expression in Hodgkin's disease: correlation with the t(14;18) translocation and Epstein-Barr virus. Am. J. Clin. Pathol., 99, 604-608.
15. Jiwa, N M., Kanavaros, P., van der Valk, P., Walboomers, J. M., Horstman, A., Vos, W., Mullink, H and Meijer, C. J. L. M (1993). Expression of c-myc and bcl-2 oncogene products in Reed-Sternberg cells independent of presence of Epstein-Barr virus. J. Clin Pathol., 46, 211-217.
16. Lones, M. A., Pinkus, G S., Shintaku, T. P. and Said, J. W. (1994) bcl-2 oncogene protein is preferentially expressed in Reed-Sternberg cells in Hodgkin's disease of the nodular sclerosis subtype. Am. J. Clin. Pathol., 102, 464-467
17. Ansari, B., Coates, P J., Greenstein, B. D. and Hall, P. A. (1993) In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J. Pathol., 170, 1-8.
18. Leoncini, L., Spina, D., Close, P., Bothur, P., Megha, T., Pacenti, L., Tosi, P., Pileri, S., De Vivo, A., Kraft, R., Laissue, J. A. and Cottier, H (1996). Abortive mitoses and nuclear DNA fragmentation in CD30+ large cells of Hodgkin's disease. Leuk. Lymphoma, 22, 119-124.
19. Harris, N. L., Jaffe, E. S., Stein, H., Banks, P. M., Chan, J. K., Cleary, M. L., Delsol, G., De Wolf-Peeters, C., Falini, B., Gatter, K. C., Grogan, T. M., Isaacson, P. G., Knowles, D. M., Mason, D. Y., Müller-Hermelink, H. K., Pileri, S. A., Piris, M. A., Ralfkiaer, E. and Warnke, R. A. (1994). A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood, 84, 1361-1392.
20. Leoncini, L., Del Vecchio, M. T., Kraft, R., Megha, T., Barbini, P., Cevenini, G., Poggi, S., Pileri, S., Tosi, P. and Cottier, H (1990). Hodgkin's disease and CD30-positive anaplastic large cell lymphomas - A continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study. Am. J Pathol., 137, 1047-1057.
21. Cattoretti, G., Pileri, S., Parravicini, C., Becker, M. H., Poggi, S., Bifulco, C., Key, G., D'Amato, L., Sabattini, E., Feudale, E., Reynolds, F., Gerdes, J. and Rilke, F. (1993). Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J. Pathol., 171, 83-98.
22. Luzi, P., Leoncini, L., Funtò, I., Bruni, A., Lazzi, S., Pacenti, L. and Tosi, P. (1994). Epstein-Barr virus infection in sinonasal non-Hodgkin's lymphomas. Virchows. Arch., 425, 121-125.
23. Wilkinson, L. (1989). SYSTAT: the system for statistics. (Evanston (IL): Systat, Inc).
24. Cross, R M. (1969). Hodgkin's disease, histological classification and diagnosis. J. Clin. Pathol., 22, 165-182.
25. Del Vecchio, M. T., Leoncini, L., Buerki, K., Kraft, R., Megha, T., Barbini, P., Tosi, P. and Cottier, H. (1991). Diffuse centrocytic and/or centroblastic malignant non-Hodgkin's lymphomas: comparison of mitotic and pyknotic (apoptotic) indices Int. J. Cancer, 47, 38-43.
26. Leoncini, L., Del Vecchio, M. T., Megha, T., Barbini, P., Galieni, P., Pileri, S., Sabattini, E., Gherlinzoni, F., Tosi, P., Kraft, R. and Cottier, H. (1993). Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas. Am. J. Pathol., 142, 755-763.
27. Khan, G. and Coates, P. J. (1994). The role of Epstein-Barr virus in the pathogenesis of Hodgkin's disease. J. Pathol., 174, 141-149.
28. Milner, A. E., Johnson, G. D. and Gregory, C. D. (1992). Prevention of programmed cell death in Burkitt lymphoma cell lines by bcl-2 dependent and -independent mechanisms. Int. J. Cancer, 52, 636-644.
29. Allen, P. D., Bustin, S. A., Macey, M. G., Johnston, D. H., Williams, N. S. and Newland, A. C. (1993). Programmed cell death (apoptosis) in immunity and haematological neoplasia. Br. J. Biomed Sci., 50, 135-149.
30. Vaux, D., Cory, S. and Adams, J. (1988). Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature, 335, 440-445.
31. Henderson, S., Rowe, M., Gregory, C., Croom-Carter, D., Wang, F., Longnecker, R., Kieff, E. and Rickinson, A. (1991). Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell, 65, 1107-1115.
32. Boise, L. H., Gonzalez-Garcia, M., Postema, C E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nuñez, G. and Thompson, C. B. (1993). bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell, 74, 597-608
33. Imamura, J., Miyoshi, I. and Koeffler, H. P. (1994). p53 in hematologic malignancies. Blood, 84, 2412-2421.